chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My lymph nodes were swollen under my arms. I went to physical therapy for 6 weeks. I am not able to lift my arm and I can't move my arm around to my back. I am supposed to start back in a couple of weeks.
Flu like symptoms starting about 12 hours after vaccination that last for 2 days.  Since then he has noted an vague "lightheaded" sensation that is slowly improving.  He has also noticed some heart palpitations.
The patient received the expired vaccine; Jynneos was administered intradermal; Case reference number US-BN-2022-004593 is a spontaneous case report initially received on 07-Nov-2022 from a pharmacist via agency (reference number: USBAV22-1883) and concerns a male patient.  The patient's medical history included lung transplant (the patient was immunocompromised).  The patient's concomitant medication details were not provided.  On 07-Nov-2022, the patient was vaccinated with the first dose of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FDP00016; expiration date: 24-Oct-2022) at a dose of 0.1 ml, administered intradermal at an unknown site of administration for monkeypox prophylaxis (explicitly coded as 'intradermal injection' and 'expired vaccine used').  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos.  Additional information received on 07-Nov-2022 from agency included expiration date of Jynneos.  Additional information received on 08-Nov-2022 from Bavarian Nordic included local BN case ID.  This case is linked with US-BN-2022-004589 due to the same reporter.; Reporter's Comments: A male patient was vaccinated on 07-Nov-2022 with the first dose of Jynneos vaccine (expiration date of vaccine was 24-Oct-2022) administered intradermally at a dose of 0,1 mL, for monkeypox prophylaxis, which is considered as expiration product administered. No associated adverse events were reported. Intradermal injection and inappropriate schedule of vaccine administered are listed per company convention. The patient's medical history included lung transplant (the patient was immunocompromised). The patient's concomitant medication details were not provided. Intradermal injection and inappropriate schedule of vaccine administered are not related to Jynneos, but to a human factor. The case is non-serious.; Sender's Comments: A male patient was vaccinated on 07-Nov-2022 with the first dose of Jynneos vaccine (expiration date of vaccine was 24-Oct-2022) administered intradermally at a dose of 0,1 mL, for monkeypox prophylaxis, which is considered as expiration product administered. No associated adverse events were reported. Intradermal injection and inappropriate schedule of vaccine administered are listed per company convention. The patient's medical history included lung transplant (the patient was immunocompromised). The patient's concomitant medication details were not provided. Intradermal injection and inappropriate schedule of vaccine administered are not related to Jynneos, but to a human factor. The case is non-serious.
Severe pain at injection site and radiating down arm/up neck and headache  started 1/27/2020 2100 and continued through 1/31/2020. Dizziness fatigue began 1/28/2020 1100 lasted through 2/4/2020. Rash at injection site observed at 0700 on 2/4/2020 still present
I had no pain, swelling or redness in or around vaccine site.  In the evening, my right hand and fingers began to swell,  The next morning my hand and fingers were throbbing and I could not make a fist.  I have iced it multiple times and the swelling is coming down today 4.11.21.
This spontaneous report was received from a Registered nurse regarding a 15 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 23-JUN-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis. No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-1804USA005153.
Increased sleep time noted since shots given, hard to arouse. Alert once awake but only awake approximately 5 to 10 minutes at a time.
About 4 weeks later, all of a sudden, I started to get a pain in my left thumb in the joint. I don't recall doing anything to injury it. It just started hurting. I went to the doctor, and he put me on an inflammatory medication, but it didn't work. I went to see an orthopedist. The orthopedist said I have slight arthritis and appendicitis in the middle joint of my thumb. I never had an issues prior to the vaccine. I was on the medication again for another 2 weeks and it still didn't help. When I went back for a follow up, the doctor gave me cortisol which brought down the inflammation immediately.
Within 10 mins of vaccination had increased heart rate, felt throat was closing, Went to ER for BENADRYL injection.
He reported that he was well at time of vaccination and only AVA was administered. One day post AVA # 3 he noticed that his left leg would twitch and he would have to stretch out to get it to relax. He reported spasms in his mid to upper back that would occur 9-10 times daily and a constant ache in his lower back. He reported that the vaccination site was sore for about 3 days. Muscle pain/spasms persisted x 10 days. He did not seek medical attention and did not take anything for the discomfort. He stated that all symptoms have resolved. ~ He reported a similar episode with receipt of AVA # 2 in Feb, in which the following day he developed back spasms and cramping. Also had spasms in left leg. Initially thought he tweaked his muscles. Symptoms lasted approx. 10 days. No recurrence of symptoms until vaccination with AVA # 3  Symptoms: MYALGIA(M791), CRAMP AND SPASM(R252).
Dizziness, Headache, Myalgia & Arthralgia Narrative:
tingling on right arm, swollen right thumb, lightheaded; denies SOB or chest pain. Vitals: 160/100, HR- 95, pulse ox- 96%, repeat B/P- 140/90, HR- 85; client is an insulin dependent DM, blood sugar- 375. Client stated she had not taken her insulin this morning, reports eating candied yams last night @ 10pm. 0912- client self injected 10 units novolog insulin pen; 0922- reports feeling better, injection still sore; cleared by site lead and released to facility director
Information has been received from a physician concerning a 19 year old female with a history of CIN 1 and Benzoyl Peroxide allergy who on 10-SEP-2007 was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast) IM (Lot# 658556/1030U). Subsequently the patient developed 2 warts on her fingers. The patient's 2 warts on her fingers persisted. The patient sought unspecified medical attention. Additional information has been requested.
At midnight  of the same day of booster shot, I woke up with chills, diarrhea and my blood pressure was 150/90. I had shortness of breath and felt ill all night. Did not have this reaction with the other Pfizer shots, except for tiredness and headache.
Rash on her arm; Felt a little itchy; Felt like an insect bit her at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE DISCOMFORT (Felt like an insect bit her at the injection site), RASH (Rash on her arm) and INJECTION SITE PRURITUS (Felt a little itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE DISCOMFORT (Felt like an insect bit her at the injection site) and INJECTION SITE PRURITUS (Felt a little itchy). On an unknown date, the patient experienced RASH (Rash on her arm). At the time of the report, INJECTION SITE DISCOMFORT (Felt like an insect bit her at the injection site), RASH (Rash on her arm) and INJECTION SITE PRURITUS (Felt a little itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown demographics. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date, the patients were vaccinated with improperly stored doses of VARIVAX injection, lot # L038132 with expiration date of 01-OCT-2017 (dose and route of administration were not reported), reconstituted with properly stored sterile diluent (manufacturer unknown). Administered doses of vaccines experienced the temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit for 15 hours and 50 minutes. There was a previous temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit for 10 hours and 45 minutes and 6 degrees Fahrenheit to 14 degrees Fahrenheit for 1 hour. Digital data logger was involved in recording the excursion. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA003977.
Vaccination - 6.3.2021 Pfizer Patient developed right leg pain  chest pain and shortness of breath about 2.5 weeks after vaccination and was admitted to the hospital 6.24.2021 for a RLE DVT and PE exactly 3 weeks after her vaccine.
PT SAYS THAT VACCINE FLUID TRAVELED TO OPPOSITE SIDE OF IM AREA AND CREATED WHAT APPEARS TO BE BROKEN BLOOD VESSELS.
4-5 days ago I started to develop little skin bumps,2 days ago they became extra itchy, now im getting so many of them around my body like small pimples and they itch so much.a day right before my second phizer shot.im afraid to go for the second shot now.what should I do? Thank you!
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 16-OCT-2015 the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L009214, expiration 17-MAR-2017, dose and route were not reported). No adverse effect was reported. This is one of several cases received from the same source. Additional information has been requested.
Severe left deltoid pain. Pain both at rest and with use. Hurts more with use. Feels like I was "punched in the arm."  At rest it's so painful I can't focus on other things.
Nausea, Vertigo, mild headache. Vomiting for one and half days.  Soreness at site of injection for one day
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 30-NOV-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September 2015, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L023936, exp. date: 15-MAR-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was dx with brst cancer; had surgery and radiation. Then became metastatic to bone, lung, stomach.  Refractory to treatment
Swelling of arm approx 2 inches below administration site to approx 2 inches above elbow; swelling about 2 inches from normal; never had a reaction to flu shot before, no swelling of throat or difficulty swallowing
Development of Lupus anticoagulant factor; bruising; This is a spontaneous report received from contactable reporter(s) (Physician) via COVACES. The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Cholesterol" (unspecified if ongoing), notes: Other medical history: Cholesterol; "Prostate" (unspecified if ongoing), notes: Other medical history: Prostate; "If covid prior vaccination: Yes" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (dose number: 2, product: COVID 19, brand: Pfizer, administration date: 05Feb2021 , location: Left arm, facility: Hospital), administration date: 05Feb2021, when the patient was 70-year-old, for Covid-19 Immunization; BNT162b2 (dose number: 1, product: COVID 19, brand: Pfizer, administration date: 14Jan2021 , location: Left arm, facility: Hospital), administration date: 14Jan2021, when the patient was 70-year-old, for Covid-19 Immunization. No other vaccine in four weeks.  The following information was reported: ANTIPHOSPHOLIPID ANTIBODIES POSITIVE (disability, life threatening) with onset May2022, outcome "not recovered", described as "Development of Lupus anticoagulant factor"; CONTUSION (disability, life threatening) with onset May2022, outcome "not recovered", described as "bruising". Clinical course: Development of Lupus anticoagulant factor noted and developed bruising after vaccine injection. Adverse events development of Lupus anticoagulant factor and bruising resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event), disability or permanent damage. The events "development of lupus anticoagulant factor" and "bruising" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Negative, notes: Covid test post vaccination. Patient never had any abnormal blood tests prior to vaccine, or any bleeding abnormalities. Therapeutic measures were not taken as a result of antiphospholipid antibodies positive, contusion.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of serious events, ANTIPHOSPHOLIPID ANTIBODIES POSITIVE, CONTUSION  cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient came in to get covid shot but did not tell that she already had two Pfizer shots. Daughter called today to notify pharmacy that she already had her covid shots and that she had some dementia, so probably didn't remember to tell us that she already had them. No adverse reaction up to this point.
Itchy spots; Rash on knees; Joint Aches; Extreme Fatigue; Headache; Body aches; Teeth Chattering, chills; Fever; Flooding of "metallic" sensation; Sore Arm; Dizziness; Hives on chest; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAROSMIA (Flooding of "metallic" sensation), PAIN IN EXTREMITY (Sore Arm), DIZZINESS (Dizziness), URTICARIA (Hives on chest) and PRURITUS (Itchy spots) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis since an unknown date. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ATORVASTATIN and AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAROSMIA (Flooding of "metallic" sensation), PAIN IN EXTREMITY (Sore Arm), DIZZINESS (Dizziness), URTICARIA (Hives on chest), ARTHRALGIA (Joint Aches), FATIGUE (Extreme Fatigue), HEADACHE (Headache), MYALGIA (Body aches), CHILLS (Teeth Chattering, chills) and PYREXIA (Fever). On 19-Feb-2021, the patient experienced PRURITUS (Itchy spots) and RASH (Rash on knees). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, Joint ache, sore arm, Chills, Pain in extremity and Fatigue, at an unspecified dose and frequency. At the time of the report, PAROSMIA (Flooding of "metallic" sensation), PAIN IN EXTREMITY (Sore Arm), DIZZINESS (Dizziness), URTICARIA (Hives on chest), PRURITUS (Itchy spots), RASH (Rash on knees), ARTHRALGIA (Joint Aches), FATIGUE (Extreme Fatigue), HEADACHE (Headache), MYALGIA (Body aches), CHILLS (Teeth Chattering, chills) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has consulted her immunologist prior to vaccination and recommended take have it.  Also insisted to have 2 dose.
Reports rash on trunk & arms 1-2 days after receiving vaccine.  States took "something" and it went away but rash returned approx 1 mo later.  Denies breathing difficulty.  Client walked into clinic to report status 10/7/13.
Developed symptoms of  V-tach arrest during a bike ride.  Myocarditis was diagnosed in the left ventricle.
Tingling numbness sensitivity and  discomfort from my knees and below all the way to my feet
With five hours of vaccination child developed fever, diarrhea and lethargy. Symptoms last five days
First time individual received a flu shot. 1 hour after immunization felt as though she was having trouble swallowing, tried to ignore it.  4 hours after flu shot reports to this facility that she is having trouble breathing.  Resp rapid and shallow, pulse rapid. Given Benadryl 50 mg IM and Epinephrine 1:1000 0.3 mg SC with no change in symptoms until ambulance arrival. Transported to ER. Was told that she had an allergic reaction and if she had reported it sooner the Benadryl probably would have taken care of it.  Put on Prednisone and given an epi pen for emergency use.  Advised to see an allergist to determine actual cause of allergic reaction. Warned that the next exposure could cause a more rapid and more severe reaction.
Info has been received from a licensed practical nurse concerning a 29-year-old male volunteer firefighter with no known drug allergies and no past medical history who on 12/02/2002 at 7:00 PM was vaccinated IM in the deltoid with a first dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M). Concomitant therapy that day at 7:00 PM included a dose of influenza virus vaccine (FLUZONE) (Batch #U0925AA) given IM in the deltoid. There was no illness at the time of vaccination. No adverse events following prior vaccinations for the pt or his siblings were reported. Two hours after receiving the vaccination, the pt was called out on a major structure fire and spent the next 20 hours at the fire scene engaged at times in heavy physical labor. On 12/03/2002 at 9:00 PM the pt developed induration and redness from his elbow to his shoulder, along with swelling, "hot to touch", and pain. He did not require medical care as a result of this. The reporter indicated that she suspects the heavy physical activity in the fire "played a major role in their reactions". It was noted that the pt recovered on 12/09/2002.The reporter indicated that 9 other pts received a dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M) and developed induration at the injection site (WAES #0212USA00729, 0212USA01192, 0212USA01193, 0304USA02075, 0304USA02076, 0304USA02077, 0304USA02078, 0304USA02079 and 0304USA02081). No further info is expected.
Vaccinated 6/17/03 right arm: DTaP, MMR. Seen in office 6/20/03 with large localized swelling at site. Received warm compresses.
Patient brought to the ED by EMS on 12/3/22 for generalized weakness, persistent cough, and confusion. En route to the ED, patient's oxygen sats was 88% so was placed on oxygen. She tested positive for COVID by PCR in the ED, and was admitted on 12/3/22 for hypoxic respiratory failure due to COVID-19 pneumonia, dysphagia and possible aspiration pneumonia, among other problems. She initially required O2 and was on decadron, however was able to be weaned off oxygen. Her COVID pneumonia resolved during her admission. Patient has received the COVID primary vaccine series and two boosters.  Of note, during admission patient continued to have persistent encephalopathy, dysphagia, and suspected LLL aspiration pneumonia. Ultimately she was transitioned to comfort focused care on 12/27, and expired in the hospital on 12/30/22. Cause of death documented in the chart is respiratory failure secondary to aspiration pneumonia.
Pt had flu shot on 10/20/10 and a TDAP on 10/21/10. Rash on torso, arms & legs (no palms, no soles) started on 10/22/10. No SOB. (+) hx of receiving TDAP with no reaction. No hx of previous flu vaccine.